A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas
NCT02395601
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
B-Cell Lymphoma
Interventions
DRUG:
CPI-1205
Sponsor
Constellation Pharmaceuticals